Pharma news
Careers
Veteran leader to stay on during transition period as adviser until his retirement later this year. 1 July 2025
Americas
This session brings together experts from Choate, Radius Health, and Syros Pharmaceuticals to examine the current policy landscape affecting life sciences patents. Discussions focus on recent developments such as the Inflation Reduction Act’s drug pricing provisions and concerns over patent examination quality at the USPTO. 30 June 2025
Americas
Insurance company Cigna claims Bristol Myers Squibb may have caused overpayments of ‘billions’ of dollars after allegedly delaying market entry of generic Pomalyst | Lawsuit follows dismissal of antitrust suit against pharma giant over same drug. 26 June 2025
Americas
This panel brings together experts from Wolf Greenfield, BlueRock Therapeutics, BioNTech, and Generate Biomedicines to explore the evolving landscape of pharmaceutical collaborations. The discussion focuses on how partnerships can accelerate drug discovery, share risks, and pool resources in today’s complex drug development environment. 25 June 2025
Careers
Trio have worked together for several years at different firms, bringing decades of experience in medical devices, robotics, and life sciences. 24 June 2025
Europe
AstraZeneca and Kudos must disclose alternative deal structures by October 2025 | Ruling aims to clarify counterfactual damages defence ahead of expert meetings. 24 June 2025
Americas
Appeals board overturns previous decision and revokes patent on treatment worth $2bn in 2024 | Teva and Generics UK successful in arguing lack of inventive step. 24 June 2025
Americas
Regeneron files motion to disqualify firm from patent and antitrust dispute | Motion cites conflict of interest due to Kirkland’s prior work for Regeneron | Kirkland denies conflict, citing screening measures. 19 June 2025
Americas
Semaglutide generics set to enter the Canadian market by 2026 after Novo Nordisk failed to maintain key patent | Speculation over whether it was a mistake or calculated move in a country known for strict drug price controls. 17 June 2025
Americas
Biotech company convinces judges over claim construction interpretation | Alnylam “acted as lexicographer” regarding a claim term | Win comes as Moderna suffers economic challenges. 5 June 2025